Bath & Body Works posted weaker first-quarter sales while implementing a strategic overhaul aimed at restoring growth momentum. The retailer exceeded its own guidance but acknowledged results remain below its brand's potential. Chief Executive Daniel Heaf emphasized the foundation being built for future performance improvement.

The company simultaneously announced that its chief financial officer will depart to join pharmaceutical-distribution firm Cencora, creating additional leadership transition during the restructuring period. This executive departure adds complexity to Bath & Body Works' turnaround efforts as it works to stabilize operations and reposition its business model.

Despite the sales decline, Bath & Body Works managed to increase profitability, reporting net income of $183 million, or $90 cents a share, compared with $105 million, or 49 cents a share, in the prior year period. The earnings improvement suggests cost management and operational adjustments are beginning to take hold.

Investors will watch closely how the company navigates this leadership change while executing its transformation strategy. The turnaround timeline extending through 2026-2027 indicates Bath & Body Works expects a gradual rather than immediate recovery, which may test shareholder patience in an increasingly competitive retail environment.